title: Hypertension during intravenous immune globulin infusion for Kawasaki's disease: an underreported phenomenon?
authors.affiliation: Yale Medical Center, New Haven, CT, USA.
authors.forename: Margaret
authors.initials: M
authors.lastname: Kissel
authors.affiliation: New York University Langone Medical Center, New York, NY, USA.
authors.forename: Colin K L
authors.initials: CK
authors.lastname: Phoon
authors.affiliation: New York University Langone Medical Center, New York, NY, USA philip.kahn@nyumc.org.
authors.forename: Philip J
authors.initials: PJ
authors.lastname: Kahn
mesh_terms: D000959:Antihypertensive Agents / Q000627:therapeutic use; D002675:Child, Preschool; D005260:Female; D006801:Humans; D006973:Hypertension / Q000150:complications* / Q000188:drug therapy; D016756:Immunoglobulins, Intravenous / Q000627:therapeutic use*; D007741:Labetalol / Q000627:therapeutic use; D009080:Mucocutaneous Lymph Node Syndrome / Q000150:complications* / Q000188:drug therapy*
chemical_list: D000959:Antihypertensive Agents; D016756:Immunoglobulins, Intravenous; D007741:Labetalol